Overall rank by patents
#30,097
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 11 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).
The verdict
St. holds 9 US patents across 11 technology areas, rank #30,097 of 50,000 tracked assignees.
ST. Marianna University School OF Medicine has been granted 9 US utility patents between 2017 and 2025, placing ST. Marianna University School OF Medicine at rank #30,097 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.3 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, ST. Marianna University School OF Medicine is one of the more focused assignees in the PatentsView dataset. By volume, St. sits between Spinnova OY (9 patents, rank #30,093) and Step2gold Co., Ltd. (9 patents, rank #30,101) - the closest US assignees by grant volume. The composite Innovation Score of 31.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 4 in the 2015–2019 window, a +25% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. ST. Marianna University School OF Medicine's 14.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark ST. Marianna University School OF Medicine against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SPINNOVA OY
9 patents
SPREADTRUM SEMICONDUCTOR (NANJING) CO., LTD.
9 patents
ST ENGINEERING IDIRECT (EUROPE) CY NV
9 patents
ST-ERICSSON SEMICONDUCTOR (BEIJING) CO., LTD
9 patents
STABILA Messgeräte Gustav Ullrich GmbH
9 patents
STAUBLI LYON
9 patents
STEERE ENTERPRISES, INC.
9 patents
STEP2GOLD CO., LTD.
9 patents
ST. MARIANNA UNIVERSITY SCHOOL OF MEDICINE
9 patents
What this shows ST. holds 9 patents at rank #30,097, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #30,097 in granted patent volume.
Other assignees with the most granted patents in ST's primary technology class.
St.'s Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
32 Top 62% higher than 38% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 22.2% |
| 2019 | 2 | 22.2% |
| 2020 | 2 | 22.2% |
| 2022 | 2 | 22.2% |
| 2025 | 1 | 11.1% |
Top 11 of 11 technology areas
Overall rank by patents
#30,097
Across all tracked assignees
31.6 out of 100
How to use this portfolio
St.'s 9 grants land it in the top 62% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.